Annual report pursuant to Section 13 and 15(d)

Discontinued Operations - Reconciliation of Loss from Discontinued Operations (Details)

v3.24.3
Discontinued Operations - Reconciliation of Loss from Discontinued Operations (Details) - USD ($)
$ in Thousands
12 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Results of operations for discontinued operations    
Research and development $ 5,185 $ 10,327
Fixed asset impairments 3,100 17,900
Inventory reserve   4,915
Gain on extinguishment of debt 808  
Loss from discontinued operations (9,464) (35,699)
iBio CDMO, LLC | Discontinued Operations    
Results of operations for discontinued operations    
Revenues   391
Cost of goods sold   52
Gross profit   339
Research and development   6,344
General and administrative 1,207 6,751
Fixed asset impairments 3,100 17,900
Loss (gain) on sale of fixed assets 4,816 (773)
Inventory reserve   4,915
Total operating expenses 9,123 35,137
Interest expense - term note payable (1,149) (900)
Gain on extinguishment of debt 808  
Other   (1)
Total other expenses (341) (901)
Loss from discontinued operations $ (9,464) $ (35,699)